One million people in the Netherlands suffer from Type 2 Diabetes and this group is growing steadily. The costs of this disease are currently estimated on a 10 billion euros per year in the Netherlands alone. This leaves large societal and economical need for the improvement of treatment. The common way to deal with this disease is to give healthy life style advice and medicine to slow down the progression of the disease. This project aims to explore the potential of a product based on a compound in nutrition, that can work together with the drug therapy to improve the treatment efficiency. We do this commissioned by TNO with the aim to activate companies from the Pharma and Nutrition industries to develop such a product.
Carlien ter Mors